Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Tissue Eng Regen Med. 2014 Apr 16;10(12):1041–1056. doi: 10.1002/term.1889

Figure 4.

Figure 4

Effects of NP addition on phenotypic response of HASMCs, as analyzed via PCR. Fold-change in mRNA expression of α-smooth muscle active (SMA), caldesmon and osteopontin, compared to EDC controls (n = 5 per treatment condition). The mRNA expression levels for the different phenotypic markers for the EDC condition was set to unity to determine the fold change in their expression for the blank- (BNP) and agent-loaded NP (ANP) treated test cases.